Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution-Non Commercial 3.0 Unported Licence

Supramolecular purification of mono-adamantane mixtures via stabilized three-shell Matryoshka assemblies

Clara Sabriàa, Tània Pèlachsa, Inhar Imazb, Daniel Maspochbc, Ferran Feixas*a and Xavi Ribas*a
aInstitut de Química Computacional i Catàlisi (IQCC), Departament de Química, Universitat de Girona, Campus Montilivi, 17003 Girona, Catalonia, Spain. E-mail: ferran.feixas@udg.edu; xavi.ribas@udg.edu
bCatalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC, The Barcelona Institute of Science and Technology, Campus UAB, Bellaterra, 08193, Catalonia, Spain
cICREA, Pg. Lluís Companys 23, 08010 Barcelona, Spain

Received 20th March 2026 , Accepted 1st June 2026

First published on 2nd June 2026


Abstract

The adamantane (Ad) core is widely used in pharmaceuticals, where it is regarded as a lipophilic “bullet” that enhances the bioactivity of Ad-bearing drugs. Despite its prevalence, little is known about its precise recognition modes within confined enzymatic active sites, and effective chromatographic strategies for the purification of mixtures of Ad derivatives remain limited. Herein, we report the supramolecular purification of mono-adamantane mixtures through the development of three-shell supramolecular Matryoshka assemblies, featuring an adamantane–cycloparaphenylene (CPP) host–guest adduct encapsulated within a tetragonal prismatic nanocage. This three-shell architecture operates via an all-in-one strategy: encapsulation is inefficient for either [8]CPP or diamondoids alone and occurs efficiently only when all three components are present simultaneously. A straightforward, solid-state filtration–redissolution protocol enables the purification of diamondoid mixtures with enhanced selectivity for amine-bearing adamantane derivatives. This approach demonstrates a high degree of supramolecular selectivity in complex diamondoid mixtures, potentially exceeding that of conventional chromatographic techniques.


Introduction

1-Adamantane monoderivatives – including amantadine, rimantadine, Ad–alkylamides, Ad–halides, Ad–COOH, and Ad–alcohols, among others – have been widely employed as therapeutic agents for numerous diseases. In addition, they serve as versatile building blocks for introducing the C10H15 adamantyl moiety into hundreds of pharmaceutical compounds via esterification, amidation, coupling, and related transformations. Since the discovery of the antiviral activity of amantadine (1-Ad–NH2) in 1964,1 numerous antivirals and other pharmaceuticals incorporating this adamantyl unit have been identified. Notably, the pseudo-spherical three-dimensional structure of adamantane imparts critical lipophilicity to these compounds, enhancing their therapeutic efficacy and establishing adamantane as one of the most successful hydrocarbon motifs for improving or conferring pharmacological activity.2,3 Resistance to amantadine as an antiviral agent has shifted its therapeutic application, and it is now used to treat dyskinesia associated with Parkinson's disease (Fig. 1a).4 Rimantadine, which contains an alkylamine group, exhibits very low hepatotoxicity and is recommended as a prophylactic agent for the prevention of influenza A in high-risk settings such as nursing homes (Fig. 1a).5 At the same time, subtle stereoelectronic or conformational changes can have a pronounced impact on antiviral efficacy. This effect is illustrated by comparisons between 2-rimantadine and 2-amantadine (substitution at a secondary carbon) and their corresponding 1-adamantyl analogues (substitution at a tertiary carbon).
image file: d6sc02321e-f1.tif
Fig. 1 (a) Structure of adamantane and some amine-substituted adamantanes as antiviral drugs in medicine (antiviral/anti-Parkinson) (on the left) and higher diamondoids used in nanotechnology (on the right). (b) Encapsulation of mono-adamantane derivatives into a supramolecular Ag-based cage.10 (c) (This work) Synthesis of a three-shell Matryoshka complex featuring a diamondoid⊂[8]CPP host–guest adduct inside a tetragonal prismatic supramolecular cage.

On the other hand, higher diamondoid derivatives such as diamantane and triamantane represent minimal molecular fragments of the diamond lattice and have been explored as diamond precursors (Fig. 1a).6 In addition, a range of advanced applications of diamondoid-containing materials has been developed, including electron emitters and catalytic sensors, owing to their intrinsic properties such as negative electron affinity, substantial steric bulk, and electron-donating ability.7 Diamondoid molecules have also demonstrated significant potential in micro- and nanoelectronic applications due to their quantum confinement effects and tunable band gaps.8

Overall, regardless of their target application, the separation and purification of diamondoid-based mixtures remain chromatographically challenging.9 Selective purification via supramolecular encapsulation is unprecedented and, if achieved, would represent a disruptive strategy for the direct isolation of specific derivatives obtained from a single synthetic sequence. In this context, Wang and co-workers reported unsuccessful attempts to supramolecularly differentiate adamantane monoderivatives (Ad, Ad–CH2OH, and Ad–COOH) using Ag- or Hg-based cages; their study instead focused on the dual-controlled release of each guest (Fig. 1b).10 Conversely, Han and co-workers reported supramolecular porous materials featuring a uniquely partitioned cavity that functions as a multifunctional extractant for the separation of brominated adamantanes and small polycyclic aromatic hydrocarbons (PAHs).11

Inspired by the efficient and aesthetic encapsulation of spherical diamondoids (e.g. adamantane, diamantane, and others) in carbon nanotubes12,13 and metallocages,14 herein we present the exquisite supramolecular purification of mono-adamantane mixtures by developing three-shell supramolecular Matryoshkas. These assemblies feature an adamantane-cycloparaphenylene (CPP)15,16 host–guest adduct encapsulated in a tetragonal prismatic nanocage 4·(BArF)8 (Fig. 1c). CPPs are fully conjugated macrocyclic hydrocarbons that have promising applications in supramolecular systems.17,18 They are known to bind many fullerenes, stabilizing them via π–π interactions19,20 and enabling the synthesis of C60/CPP-based [2]catenanes.21,22 More recently, they have been shown to encapsulate other molecules via C–H⋯π interactions, such as metallocenes23 or PAHs.24 Our group has previously reported size-tunable tetragonal prismatic cages formed by two Zn–TCPP (5,10,15,20-tetrakis(4-carboxyphenyl)-porphyrin Zn(II)) units acting as the apical “caps”, and four Pd(II) macrocyclic complexes forming the walls.25,26 The cage size can be tuned by varying the Zn–Zn distance through the use of different macrocyclic clips. As well, a three-shell Matryoshka complex has been previously reported by our group, consisting of a C60⊂[10]CPP complex encapsulated inside the 6·(BArF)8 cage, with a Zn–Zn distance of 16.8 Å.27 In the present work, a smaller nanocage 4·(BArF)8 with a Zn–Zn distance of 14.1 Å is used, which is known to exhibit high affinity towards fullerenes28,29 and pyridine-based catalysts.30 The stability of the three-shell complexes reported herein arises from apical-Zn–TCPP anchoring of the mono-adamantane moiety and the stabilization of the CPP ring within the cavity. Notably, efficient complex formation occurs only when all three components are present simultaneously, resulting in a marked enhancement in stability. Nevertheless, subtle structural differences among the adamantane derivatives translate into clear trends in encapsulation affinity, enabling a straightforward solid–liquid supramolecular filtration–purification process.

Results and discussion

With the aim of encapsulating diamondoids in a minimalistic form of a carbon nanotube, simple CPP nanorings were selected as hosts. The diameter of CPPs de-pends on the number of phenyl rings they contain (9.8 Å for [7]CPP, 11 Å for [8]CPP, 12 Å for [9]CPP, and 13.7 Å for [10]CPP). Accordingly, molecular dynamics (MD) simulations were used to predict which CPP provides the most suitable diameter to encapsulate diamondoids. Adamantane (i), the smallest diamondoid, has an approximate size of 4.3 Å, whereas diamantane (e) has the same size on the shortest axis but extends to 6.9 Å along its longest axis (Fig. S90a). These two diamondoids were selected as guest models for simulations with [n]CPP nanorings (n = 7, 8, and 9).

Spontaneous binding MD simulations were performed in acetonitrile (MeCN), starting with the unbound diamondoid placed ∼15 Å from the center of the nanoring, in order to assess the encapsulation and guest stability. Among all the nanorings studied, only [8]CPP (eight phenyl rings, diameter ≈ 11 Å; Fig. S90) transiently accommodated both adamantane i and diamantane e. Based on this result, experimental encapsulation was carried out using various adamantane derivatives by mixing equimolar amounts of guest and host ([8]CPP) in dichloromethane (DCM). 1H-NMR analysis revealed small chemical shifts for both [8]CPP and guest (Fig. S1–S14), corresponding to very low association constants (<0.5 × 102 M−1) (Table S1), in line with the transient binding observed in the MD simulations. These results clearly indicate that [8]CPP alone is insufficient to stabilize the diamondoid⊂[8]CPP assembly.

To further stabilize the diamondoid⊂[8]CPP complex through additional confinement, its encapsulation within the cavity of the tetragonal prismatic nanocage 4·(BArF)8 was studied experimentally. First, the encapsulation of [8]CPP was carried out by adding two equivalents of [8]CPP in DCM to a solution of the cage in MeCN, followed by stirring at room temperature overnight. Successful encapsulation was confirmed by high-resolution mass spectrometry (HRMS) (Fig. 2c and S15) and 1H-NMR spectroscopy, which showed broadening of the cage signals and the appearance of a new signal at 6.21 ppm corresponding to encapsulated [8]CPP (Fig. 2d, S16 and S17).


image file: d6sc02321e-f2.tif
Fig. 2 (a) Structure of the guests tested for encapsulation, showing the ones that give the formation of a diamondoid⊂[8]CPP⊂4·(BArF)8 Matryoshka complex on the top left (a–h), those 2-substituted that show encapsulation on the bottom (a-2, c-2, and d-2) and those that do not on the top right (i-l); guests that form the Matryoshka complex are in order of affinity. (b) Synthesis of a Matryoshka complex using cage 4·(BArF)8 with [8]CPP and the adamantane derivative a containing an amine substituent. (c) HRMS spectra of the encapsulation of [8]CPP (top) and the subsequent encapsulation of guest a (bottom) to give the formation of the Matryoshka complex a⊂[8]CPP⊂4·(BArF)8. (d) Stacked 1H-NMR spectra (CD3CN) for the empty cage (top), [8]CPP⊂4·(BArF)8 (middle), and a⊂[8]CPP⊂4·(BArF)8 (bottom). The peak of the encapsulated [8]CPP is marked in blue, and peaks of the encapsulated adamantane a (at negative chemical shifts) are marked in orange and zoomed.

The formation of a Matryoshka-like complex was then investigated by adding adamantane derivatives (Fig. 2a). In a typical procedure, two equivalents of the adamantane guest in DCM were added to a preformed solution of [8]CPP⊂4·(BArF)8 in MeCN. The mixture was stirred at room temperature overnight and analyzed by HRMS and 1H-NMR. Initial tests with unsubstituted adamantane were unsuccessful, and only signals corresponding to [8]CPP encapsulation were observed in the HRMS spectra. We hypothesized that the introduction of an amine group to the adamantane core could enable stable encapsulation via coordination of the N atom to the Zn ion of the porphyrin unit. Accordingly, adamantanes bearing amine groups at position 1 (a–d) were tested, confirming their encapsulation by HRMS for all four guests (Fig. 2c, S18, S25, S28 and S31). The 1H-NMR spectra revealed a new set of signals for the cage, consistent with Matryoshka complex formation, along with a new set of peaks in the negative region corresponding to the adamantane guests (Fig. 2d, S19, S26, S29 and S32). The upfield shifts of the amine-substituted adamantanes indicate confinement within the supramolecular cage cavity. These results demonstrate that amine-substituted adamantanes with chains of varying lengths (–NH2 for c, –CH2NH2 for a, and –CH2CH2NH2 for d) can form the three-shell Matryoshka complex. Notably, even the presence of a methyl group at the α-position to the amine, as in rimantadine b, does not disrupt Zn⋯N coordination, and the Matryoshka complex formation is still observed. The adamantane derivative h, containing four amine groups replacing the tertiary carbons of the adamantane core, also forms the Matryoshka complex (Fig. S47–S49), as evidenced by HRMS; however, peaks corresponding to the sole encapsulation of [8]CPP are similarly prominent, suggesting a smaller association constant than for a–d, and comparable to that of [8]CPP alone. Interestingly, some diamondoids lacking amine groups were also weakly encapsulated, including diamantane e (Fig. S38–S40), 1-adamantanemethanol (f) (Fig. S41–S43), and 1-adamantanecarboxylic acid (g) (Fig. S44–S46). In contrast, adamantanes containing halogens (–F for j, –Cl for k, and –Br for l) showed no evidence of encapsulation by either HRMS or 1H-NMR (Fig. S59 and S60).

The 2-adamantane analogues (substitution at the tertiary carbon) of the amine-substituted guests a, c, and d were also examined (a-2, c-2, and d-2). Encapsulation was confirmed for all by HRMS and 1H-NMR (Fig. S50–S58), with no noticeable differences compared to their 1-substituted counterparts.

Finally, encapsulation experiments performed for all tested diamondoids in the absence of [8]CPP and using only the nanocage 4·(BArF)8, showed no evidence of host–guest assemblies by HRMS or 1H-NMR (Fig. S61–S64), with only signals corresponding to empty cage being detected.

Competition experiments

We hypothesized that fine-tuning the substitution of the adamantane core would significantly influence the affinity of each mono-adamantane guest, arising from a dual stabilization mechanism: encapsulation within the [8]CPP nanoring and anchoring to the Zn–TCPP moiety of the cage. To test this hypothesis, competition experiments were conducted among the different adamantane derivatives and monitored by HRMS and 1H-NMR, allowing us to establish an affinity trend for derivatives a–h (Fig. 2a). When mixtures of amine-1-substituted adamantanes and diamantane (a–c and e) were examined in the presence of [8]CPP⊂4·(BArF)8, only guest a was observed to be encapsulated by HRMS (Fig. S65). In contrast, when b, c, and e were combined, HRMS showed encapsulation of b and c in a 2[thin space (1/6-em)]:[thin space (1/6-em)]1 ratio, with no inclusion of e (Fig. S67). Similarly, competition between amine-containing adamantanes c and d yielded the Matryoshka complex in a 1[thin space (1/6-em)]:[thin space (1/6-em)]1 ratio (Fig. S68). These results indicate that cage 4·(BArF)8 exhibits higher affinity for amine-bearing 1-substituted adamantanes driven by Zn⋯N coordination, whereas diamantane e, lacking an anchoring group, shows negligible binding in the presence of amine-1-substituted adamantanes. The presence of a CH2 spacer between the adamantane core and the amine in guest a, compared to amantadine (c), favored the Zn⋯N axial-metal ligand coordination while stabilizing the adamantane in the nanoring and maintaining [8]CPP at a non-repulsive distance from the porphyrin. In the case of rimantadine (b), which features a methyl group next to the amine substituent while retaining the same chain length, the affinity is reduced compared to a, likely due to the clashing of the methyl with the porphyrin and the nanoring (see below). On the other hand, when the amine is directly attached to the adamantane core (c) or separated by two CH2 units (d), the affinity is further diminished. Finally, bare diamantane (e), which cannot engage in Zn⋯N coordination, also displays low affinity. Interestingly, when the smallest nitrogen-containing adamantane h was mixed with diamantane e, HRMS revealed predominant encapsulation of e along with minor peaks corresponding to h (Fig. S72). The steric hindrance between the porphyrin and [8]CPP can rationalize this behavior, imposed when the nitrogen atom is directly attached to the adamantane core, weakening the Zn⋯N interaction with the porphyrin. Finally, when diamantane e was combined with adamantanes f and g, the Matryoshka complexes were formed in comparable amounts for all three guests (Fig. S71), indicating nearly equivalent affinities. These results suggest that guests f and g may engage in weak attractive interactions with the Zn–TCPP unit, while the elongated size of e contributes to its stabilization within the Matryoshka complex.

The amine-2-substituted adamantanes a-2, c-2, and d-2 exhibit the same affinity trend as their 1-substituted analogues a, c, and d (Fig. S80 and S81), indicating that the substitution position has little impact. For example, when the amine-1-substituted adamantanes a, c, or d were mixed with their corresponding 2-substituted analogues a-2, c-2, or d-2 and analyzed by 1H-NMR, both guests were encapsulated in nearly equal ratios (1.4[thin space (1/6-em)]:[thin space (1/6-em)]1 for a[thin space (1/6-em)]:[thin space (1/6-em)]a-2, 0.9[thin space (1/6-em)]:[thin space (1/6-em)]1 for c[thin space (1/6-em)]:[thin space (1/6-em)]c-2, and 1.2[thin space (1/6-em)]:[thin space (1/6-em)]1 for d[thin space (1/6-em)]:[thin space (1/6-em)]d-2, Fig. 3 and S77–S79). These results indicate that the affinity is dictated not by the position of substitution (1- vs. 2-), but by the nature of the substituent itself. This behavior is consistent with the pseudo-spherical shape of the adamantane core, which allows effective accommodation within the [8]CPP cavity regardless of substitution at a tertiary or secondary carbon.


image file: d6sc02321e-f3.tif
Fig. 3 (a) Competition experiment between 1- and 2-substituted adamantanes in the presence of [8]CPP⊂4·(BArF)8. (b) Stacked 1H-NMR (CD3CN) showing the formation of both Matryoshka complexes d⊂[8]CPP⊂4·(BArF)8 (peaks of the [8]CPP marked in orange) and d-2⊂[8]CPP⊂4·(BArF)8 (peaks of the [8]CPP marked in purple) in a 1.2[thin space (1/6-em)]:[thin space (1/6-em)]1 ratio.

The insight gained from these competitive studies prompted us to attempt the direct purification of a complex mixture containing a, c, g, i, and l. To this end, 4·(BArF)8 was combined with a chloroform solution of the mixed mono-adamantanes and excess [8]CPP. HRMS monitoring revealed that only a was encapsulated, while c, g, i, and l remained in solution (Fig. S74). When only c, g, i, and l were present, encapsulation occurred exclusively for c, consistent with the competition studies (Fig. S73). Hence, to design a practical purification protocol, we tested a solid-state encapsulation strategy. A small column packed with Celite® was loaded with solid [8]CPP⊂4·(BArF)8, and a chloroform solution of a, c, g, i, and l was flashed through the column five times (Fig. 4). This procedure efficiently trapped a in the Matryoshka assembly, whereas c, g, i, and l eluted in the chloroform fraction (Fig. 4 and S75). The solid Matryoshka was subsequently rinsed with fresh chloroform and redissolved in MeCN. Subsequent acidic treatment disassembled the cage, releasing [8]CPP and a, which were readily recovered by flash chromatography. The efficient incorporation of guest a into [8]CPP⊂4·(BArF)8 is attributed to the large cage entrances and the small size of the mono-adamantane. Notably, when empty 4·(BArF)8 was used in the solid state and flashed with a chloroform solution of [8]CPP and the mono-adamantane mixture, no encapsulation of either the nanoring or the mono-adamantanes was observed. This result indicates that the nanoring dimensions and the lack of dynamic gate breathing in the solid state prevent [8]CPP entry into the cage (Fig. S76).


image file: d6sc02321e-f4.tif
Fig. 4 (a) Schematic experiment showing the solid-state purification system used to purify a from a mixture of adamantane derivatives (a, c, g, i, and l, 1 eq. of each). (b) HRMS showing the formation and recovery of the single Matryoshka complex a⊂[8]CPP⊂4·(BArF)8 (peaks marked in orange) and empty 4·(BArF)8 (peaks marked in grey). (c) 1H-NMR (in CDCl3) of the initial solution of adamantane derivatives (top) and after passing it through the mini-column (bottom), observing the disappearance of a peak corresponding to guest a.

Affinity constants

Affinity constants between [8]CPP and the diamondoid guests were determined by 1H-NMR titrations in CDCl3, in which increasing amounts of the guest were added to a solution of fixed [8]CPP concentration (Fig. S83–S87). Various adamantane derivatives were examined (a, e, g, i, k), revealing low association constants on the order of 2–60 M−1 (Table S1), indicating very weak host–guest interactions.

The affinity between 4·(BArF)8 and [8]CPP was also measured by 1H-NMR titration in a CD2Cl2[thin space (1/6-em)]:[thin space (1/6-em)]CD3CN (9[thin space (1/6-em)]:[thin space (1/6-em)]1) mixture to solubilize both components (Fig. 5a and S88). A Ka value of (1.5 ± 0.11) × 103 M−1 was obtained (Table S1), which is two orders of magnitude lower than that reported for the analogous system with [10]CPP and the larger cage 6·(BArF)8.27


image file: d6sc02321e-f5.tif
Fig. 5 (a) Titration experiment to extract the affinity constant for [8]CPP⊂4·(BArF)8. Stacked 1H-NMR (CD2Cl2) with the peaks of the empty cage marked in grey and peaks of [8]CPP⊂4·(BArF)8 marked in blue. (b) Titration experiment to extract the affinity constant for a⊂[8]CPP⊂4·(BArF)8. Stacked 1H-NMR (CD2Cl2) with the disappearing peaks of the empty cage marked in grey and appearing peaks of a⊂[8]CPP⊂4·(BArF)8 marked in orange.

The affinity constant for the a⊂[8]CPP⊂4·(BArF)8 complex was determined using a similar 1H-NMR titration protocol (Fig. 5b and S89). A solution containing both guests (a and [8]CPP) was added to a solution of empty 4·(BArF)8 at constant concentration in CD2Cl2[thin space (1/6-em)]:[thin space (1/6-em)]CD3CN (9[thin space (1/6-em)]:[thin space (1/6-em)]1). A Ka value of (1.6 ± 0.6) × 105 M−1 was obtained (Table S1), representing an increase of two orders of magnitude from that of the [8]CPP alone. This result indicates that the presence of the adamantane derivative promotes encapsulation of [8]CPP, facilitating the formation of the Matryoshka complex.

Owing to the high Ka observed for the a⊂[8]CPP⊂4·(BArF)8 Matryoshka assembly (>105 M−1), we focused on its crystallization for single-crystal X-ray diffraction (SCXRD) analysis. Suitable crystals were obtained and measured at the SCXRD facility at the Alba-BCN synchrotron using carefully prepared capillaries containing mother liquor to prevent solvent loss and rapid amorphization. SCXRD analysis confirmed the formation of the expected metal–organic cage; however, the resolution within the internal cavity was limited, and only diffuse electron density was observed. This inner electron density is consistent in both shape and spatial distribution with the presence of the encapsulated [8]CPP, but it cannot be unambiguously assigned. To further support the proposed structural model, refinement attempts were made using a rigid fragment derived from quantum-chemical calculations. These attempts were unsuccessful due to the incompatibility between the crystallographic symmetry of the cage (P4) and the symmetry of the calculated guest. Even after reducing the symmetry during refinement, a satisfactory fit for the fully encapsulated molecule could not be obtained. Nevertheless, partial refinement of the encapsulated nanoring was achieved, allowing the localization of four benzene rings of the [8]CPP within the cavity (Fig. S99) and thereby confirming the encapsulation of [8]CPP inside cage 4.

Computational studies

Since SCXRD characterization was inconclusive, molecular dynamics (MD) simulations were carried out to gain further insight into the positioning of mono-adamantane⊂[8]CPP complexes within the cage cavity. In all cases, the mono-adamantane guest together with [8]CPP was manually placed inside 4·Cl8 as the starting configuration for the simulations. Simulations were performed with explicit MeCN as solvent and Cl ions as a model counteranion for BArF. Simulations of [8]CPP alone inside 4·Cl8 revealed that the encapsulated nanoring remains dynamic and is not well-centered within the cage cavity, instead shifting toward one of the cage windows (Fig. S91). This behavior is likely driven by the maximization of π–π interactions between the phenyl rings of [8]CPP and the cage clips, as evidenced by the noncovalent interaction (NCI) surface analysis (Fig. S94). For the Matryoshka a⊂[8]CPP⊂4·Cl8, the complex adopts a well-defined orientation, with [8]CPP again displaced toward a cage window (Fig. 6a and S91). Notably, the amine moiety of a forms effective apical coordination to the Zn–porphyrin, while π–π interactions between [8]CPP and the clips are maintained. This translates into a highly stable complex, as further illustrated by the NCI surface analysis (Fig. 6a and S94). These results indicate that the CH2 spacer between the adamantane core and the amine group is essential for enabling effective N⋯Zn coordination while minimizing steric clash between the porphyrin and [8]CPP. Additionally, the NH2 group interacts with [8]CPP, stabilizing the nanoring in a fixed orientation (Fig. S95b).
image file: d6sc02321e-f6.tif
Fig. 6 (a) Snapshot of the MD simulations of a⊂[8]CPP⊂4·Cl8 with side and top views. Zn⋯N interaction between the porphyrin and the amine group of the adamantane is shown in a black dashed line with a distance of 1.9 Å, with the representation of the NCI surface (weak van der Waals interactions in green and positive interactions in blue). π–π interactions between [8]CPP and the phenyl rings on the clips are also represented with a black dashed line, with the representation of the NCI surface. Hydrogens of the cage and the [8]CPP have been omitted for clarity. (b) Description of the two CVs used in the WT-MetaD simulations for the competition between a⊂[8]CPP and e⊂[8]CPP, being the distance between the center of masses of the cage (CageCOM) and the center of masses of each CPP (CPP1COM for the diamantane e in green and CPP2COM for the adamantane a in orange). Free energy landscape for the competition, with the two metastable states (A) and (B) corresponding to the encapsulation of each complex.

In the case of b⊂[8]CPP⊂4·Cl8, the presence of the α-methyl substituent prevents full encapsulation of the adamantane core within [8]CPP (Fig. S95a), and no NH2⋯[8]CPP interaction is observed due to the increased distance (Fig. S95b), resulting in reduced stabilization and lower binding affinity. For c⊂[8]CPP⊂4·Cl8, the [8]CPP displays increased dynamic mobility, rotating between cage windows. Here, the amine is directly attached to the adamantane core, and full encapsulation by [8]CPP is hindered due to steric clash with the Zn–porphyrin unit (Fig. S95b), leading to a less stable complex with reduced affinity. By contrast, d⊂[8]CPP⊂4·Cl8, which features a longer –CH2CH2NH2 linker, exhibits effective Zn⋯N coordination along with π–π interactions between [8]CPP and the cage clips. Guests e–g, lacking the N⋯ZnTCPP anchoring motif, behave similarly, with [8]CPP preferentially positioned toward a single window. For diamantane e, the guest adopts a vertical orientation relative to the porphyrin planes and is encapsulated by [8]CPP along its shortest axis (Fig. S93).

NCI calculations of a representative frame for the e⊂[8]CPP⊂4·Cl8 and i⊂[8]CPP⊂4·Cl8 complexes show that the diamantane e presents more interactions with the [8]CPP than adamantane i (NCI volume of 737.31 Å3 for e and 586.86 Å3 for i), in line with experimental observations (Fig. S98). For f and g, Zn⋯O interactions are observed (Fig. S91). Finally, in h⊂[8]CPP⊂4·Cl8, the smallest amine-containing adamantane, increased guest mobility is observed due to its small size, which precludes effective Zn–TCPP interaction while maintaining favorable interactions with [8]CPP. This behavior aligns with its weak binding affinity, being the last of the preferred guests in the series (Fig. 2a). MD simulations of the 2-substituted adamantanes (a-2, c-2, and d-2) revealed similar trends to their corresponding 1-substituted analogues (Fig. S92).

To gain further insight into the competition experiments, well-tempered metadynamics (WT-MetaD) simulations were performed to model the exchange between two adamantane⊂[8]CPP complexes of differing affinity. Adamantanes a and e were selected due to the markedly different affinities. In the WT-MetaD setup, the e⊂[8]CPP complex was initially placed inside the cage 4·Cl8, while a⊂[8]CPP was positioned outside. Four 1 µs replicas were conducted, using two collective variables (CVs) corresponding to the distances between the center of mass of the cage and each [8]CPP (see Fig. 6b and SI for details). The simulations first revealed rapid release of e⊂[8]CPP and simultaneous encapsulation of a⊂[8]CPP (Fig. 6b, S96 and S97). Subsequently, multiple binding and unbinding events involving both guest⊂[8]CPP complexes were observed throughout the simulations. Overall, a⊂[8]CPP remained encapsulated for longer periods, reflecting its higher affinity imparted by the N⋯ZnTCPP anchoring handle, whereas e⊂[8]CPP spent a larger fraction of time unbound. These results confirm the relative experimentally observed affinity trend and underscore the critical role of the anchoring interaction in governing guest selectivity.

Conclusions

We have designed a three-shell Matryoshka assembly platform that enables the cooperative encapsulation of diamondoids and nanorings within the cavity of a tetragonal prismatic supramolecular cage. Selective encapsulation is achieved by fine-tuning the substitution pattern of mono-adamantane derivatives, which modulates a dual stabilization mechanism that combines confinement within the [8]CPP nanoring and apical Zn–TCPP anchoring interactions. This Matryoshka assembly operates through an all-in-one strategy: encapsulation is inefficient for [8]CPP or diamondoids individually and becomes highly efficient when all three components act cooperatively. As a result, the Matryoshka architecture allows the selective purification of diamondoid mixtures both in solution and, remarkably, in the solid state via a simple filtration–redissolution protocol. This level of selectivity among complex diamondoid mixtures surpasses that achievable by chromatographic techniques. We anticipate that this approach will inspire new supramolecular strategies for the purification of adamantane-based pharmaceuticals and higher diamondoids of relevance to nanotechnological applications.

Author contributions

C. S. performed the experiments and MD studies. T. P. contributed with experiments on multishell assemblies using cage 4·(BArF)8. I. I. and D. M. performed the XRD studies. F. F. and X. R. supervised and conceptually design the study, discussed the results, and wrote the manuscript.

Conflicts of interest

There are no conflicts to declare.

Data availability

The data that support the findings of this study are available within the article and supplementary information (SI). Computational data is available via Zenodo under the following link: https://doi.org/10.5281/zenodo.18378892.

Supplementary information: materials, instrumentation, experimental procedures, spectroscopic and photophysical characterization of all compounds, and computational details. See DOI: https://doi.org/10.1039/d6sc02321e.

Acknowledgements

We thank MCIN Spain (PID2022-136970NB-I00 and TED2021-130573B-I00 to X. R., RYC2020-029552-I, and PID2022-141676NB-I00 to F. F.) and Generalitat de Catalunya (2021SGR00475, 2021SGR00487). C. S. and T. P. thank UdG and MCIN for IF and FPU PhD grants, respectively. X. R. acknowledges an ICREA-Academia award. I. I. and D. M. acknowledge the Catalan AGAUR (project 2021 SGR 00458), and the CERCA program/Generalitat de Catalunya. We thank Judith Juanhuix for support in the BL13-XALOC. We also thank the Ochoa Centers of Excellence program, grant CEX2021-001214-S, funded by MCIN/AEI/10.13039.501100011033 to D. M.

Notes and references

  1. W. L. Davies, R. R. Grunert, R. F. Haff, J. W. McGahen, E. M. Neumayer, M. Paulshock, J. C. Watts, T. R. Wood, E. C. Hermann and C. E. Hoffmann, Science, 1964, 144, 862–863 CrossRef CAS PubMed.
  2. L. Wanka, K. Iqbal and P. R. Schreiner, Chem. Rev., 2013, 113, 3516–3604 CrossRef CAS PubMed.
  3. V. M. Dembitsky, T. A. Gloriozova and V. V. Poroikov, Biochem. Biophys. Res. Commun., 2020, 529, 1225–1241 CrossRef CAS PubMed.
  4. E. T. Warda, M. B. El-Ashmawy, E.-S. E. Habib, M. S. M. Abdelbaky, S. Garcia-Granda, S. Thamotharan and A. A. El-Emam, Sci. Rep., 2022, 12, 21058 CrossRef CAS PubMed.
  5. A. S. Monto, S. E. Ohmit, K. Hornbuckle and C. L. Pearce, Antimicrob. Agents Chemother., 1995, 39, 2224–2228 CrossRef CAS PubMed.
  6. M. Bonsir, A. R. Kennedy and Y. Geerts, ChemistryOpen, 2022, 11, e202200031 CrossRef CAS PubMed.
  7. K.-W. Yeung, Y. Dong, L. Chen, C.-Y. Tang, W.-C. Law and G. C.-P. Tsui, Nanotechnol. Rev., 2020, 9, 650–669 CrossRef CAS.
  8. W. A. Clay, Z. Liu, W. Yang, J. D. Fabbri, J. E. Dahl, R. M. K. Carlson, Y. Sun, P. R. Schreiner, A. A. Fokin, B. A. Tkachenko, N. A. Fokina, P. A. Pianetta, N. Melosh and Z.-X. Shen, Nano Lett., 2009, 9, 57–61 CrossRef CAS PubMed.
  9. T. Kusaba, Y. Kuranaga and S. Miyamoto, J. Chem. Eng. Jpn., 2013, 46, 262–270 CrossRef CAS.
  10. Y. Yao, C. Shao, S. Wang, Q. Gong, J. Liu, H. Jiang and Y. Wang, Commun. Chem., 2024, 7, 43 CrossRef CAS PubMed.
  11. L.-J. Wang, Z.-E. Zhang, Y.-Z. Zhang and Y.-F. Han, Angew. Chem., Int. Ed., 2024, 63, e202407278 CrossRef CAS PubMed.
  12. M. Yao, P. Stenmark, E. Abou-Hamad, F. Nitze, J. Qin, C. Goze-Bac and T. Wågberg, Carbon, 2011, 49, 1159–1166 CrossRef CAS.
  13. Y. Li, Z. Yao, B.-B. Liu, L. Wang, C. Pei, Y. Yuan and J. Ai, Philos. Mag., 2019, 99, 401–418 CrossRef CAS.
  14. K. Iizuka, H. Takezawa and M. Fujita, Angew. Chem., Int. Ed., 2025, 64, e202422143 CrossRef CAS PubMed.
  15. R. Jasti, J. Bhattacharjee, J. B. Neaton and C. R. Bertozzi, J. Am. Chem. Soc., 2008, 130, 17646–17647 CrossRef CAS PubMed.
  16. J. Xia, J. W. Bacon and R. Jasti, Chem. Sci., 2012, 3, 3018–3021 RSC.
  17. D. Lu, Q. Huang, S. Wang, J. Wang, P. Huang and P. Du, Front. Chem., 2019, 7, 668 CrossRef CAS PubMed.
  18. Y. Xu and M. von Delius, Angew. Chem., Int. Ed., 2020, 59, 559–573 CrossRef CAS PubMed.
  19. T. Iwamoto, Y. Watanabe, T. Sadahiro, T. Haino and S. Yamago, Angew. Chem., Int. Ed., 2011, 50, 8342–8344 CrossRef CAS PubMed.
  20. X. Chang, Y. Xu and M. von Delius, Chem. Soc. Rev., 2024, 53, 47–83 RSC.
  21. F. M. Steudel, E. Ubasart, L. Leanza, M. Pujals, T. Parella, G. M. Pavan, X. Ribas and M. von Delius, Angew. Chem., Int. Ed., 2023, 62, e202309393 CrossRef CAS PubMed.
  22. F. M. Steudel, C. Sabrià, M. D. Piane, F. Feixas, X. Ribas, G. M. Pavan and M. von Delius, Chem. Sci., 2025, 16, 21908–21916 RSC.
  23. H. Kwon, B. S. Newell and C. J. Bruns, Nanoscale, 2022, 14, 14276–14285 RSC.
  24. H. Kwon and C. J. Bruns, Nano Res., 2022, 15, 5545–5555 CrossRef CAS.
  25. C. García-Simón, M. Garcia-Borràs, L. Gómez, T. Parella, S. Osuna, J. Juanhuix, I. Imaz, D. Maspoch, M. Costas and X. Ribas, Nat. Commun., 2014, 5, 5557 CrossRef PubMed.
  26. E. Ubasart, C. García-Simón, M. Pujals, K. Asad, N. Chronakis, T. Parella and X. Ribas, Org. Chem. Front., 2021, 8, 4101–4105 RSC.
  27. E. Ubasart, O. Borodin, C. Fuertes-Espinosa, Y. Xu, C. García-Simón, L. Gómez, J. Juanhuix, F. Gándara, I. Imaz, D. Maspoch, M. von Delius and X. Ribas, Nat. Chem., 2021, 13, 420–427 CrossRef CAS PubMed.
  28. C. Fuertes-Espinosa, C. García-Simón, M. Pujals, M. Garcia-Borràs, L. Gómez, T. Parella, J. Juanhuix, I. Imaz, D. Maspoch, M. Costas and X. Ribas, Chem, 2020, 6, 169–186 CAS.
  29. C. García-Simón, C. Colomban, Y. A. Çetin, A. Gimeno, M. Pujals, E. Ubasart, C. Fuertes-Espinosa, K. Asad, N. Chronakis, M. Costas, J. Jiménez-Barbero, F. Feixas and X. Ribas, J. Am. Chem. Soc., 2020, 142, 16051–16063 CrossRef PubMed.
  30. C. García-Simón, R. Gramage-Doria, S. Raoufmoghaddam, T. Parella, M. Costas, X. Ribas and J. N. H. Reek, J. Am. Chem. Soc., 2015, 137, 2680–2687 CrossRef PubMed.

This journal is © The Royal Society of Chemistry 2026
Click here to see how this site uses Cookies. View our privacy policy here.